• Profile
Close

Initial results of ixekizumab efficacy and safety in real-world plaque psoriasis patients: A multicenter retrospective study

Journal of the European Academy of Dermatology and Venereology Oct 18, 2018

Deza G, et al. - In a cohort of real-life plaque psoriasis patients, researchers assessed the effectiveness and safety of ixekizumab. They retrospectively reviewed the charts of 100 patients with moderate to severe plaque psoriasis treated with ixekizumab at seven Spanish dermatological centers. Clinical variables like body mass index, disease duration, or the presence of psoriatic arthritis did not affect ixekizumab response. Nonetheless, at week 12-16, significantly higher PASI 75 response rate was demonstrated by the bio-naive group vs patients previously exposed to biologic agents. The usefulness and safety of initial experience with ixekizumab in the treatment of plaque psoriasis patients was confirmed in the findings.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay